In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study

INTRODUCTION: The SARS-CoV-2 Omicron variant has decreased virulence and pathogenicity, yet the number of Omicron infections worldwide is unprecedentedly high, with rather high mortality and severe disease rate. Chronic kidney disease (CKD) patients are particularly vulnerable to the SARS-CoV-2 Omic...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yue, Guo, Yifei, Ying, Huajian, Yu, Weien, Chen, Shiqi, Zhang, Yao, Zhang, Shenyan, Lin, Yanxue, Sun, Feng, Zhang, Yongmei, Yu, Jie, Ma, Ke, Qin, Lunxiu, Long, Feng, Zhu, Haoxiang, Mao, Richeng, Xue, Jun, Zhang, Jiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585898/
https://www.ncbi.nlm.nih.gov/pubmed/37853317
http://dx.doi.org/10.1186/s12879-023-08620-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585898/
https://www.ncbi.nlm.nih.gov/pubmed/37853317
http://dx.doi.org/10.1186/s12879-023-08620-2

Ejemplares similares